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Introduction: Wegener’s granulomatosis presenting as diffuse alveolar hemorrhage is uncommon. However, the
recognition of multisystem disease involving joints, kidney, eye and lung is critical for diagnosing Wegener's
vasculitis. This is not the first report of this kind in the literature.
Case presentation: A 51-year-old Croatian woman presented to our Emergency Department with a history of
progressively worsening productive cough and shortness of breath, epistaxis and two episodes of hemoptysis. She
developed respiratory failure due to diffuse alveolar hemorrhage, which was successfully treated with high-dose
steroids, cyclophosphamide and plasmapheresis. Her clinical course was complicated with methicillin-resistant
Staphyloccocus aureus pneumonia, which has been associated with Wegener’s granulomatosis flares.
Conclusion: The recognition of multisystem disease is critical for diagnosing Wegener's vasculitis. Diffuse alveolar
hemorrhage can be a fulminant manifestation of Wegener’s granulomatosis, in which case immediate and
aggressive treatment with pulse steroids, high-dose cyclophosphamide and plasma exchange can be life-saving.Introduction
Wegener’s granulomatosis (WG) is an antineutrophil
cytoplasmic antibody (ANCA)-associated small vessel
vasculitides. The clinical manifestations of vasculitides
are diverse, and this is reflected in the manner of their
presentation in patients in an intensive care unit (ICU).
Typically, this involves the lungs or kidneys. Systemic
necrotizing vasculitis represents a major challenge in
critical care units, thus, early and accurate diagnosis and
aggressive treatment are essential to improve outcome.
The first presentation of a patient with WG to the ICU
may be with respiratory failure and nonspecific changes
on his or her chest radiograph rather than the more
classical renal failure. We report an unusual case of WG
in which the patient presented with diffuse alveolar
hemorrhage (DAH), and we explore the differential diag-
nosis and discuss its treatment in the ICU.* Correspondence: jdecadenasg@hotmail.com
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A 51-year-old Croatian Caucasian woman presented to
our Emergency Department (ED) with a history of pro-
gressively worsening productive cough and shortness of
breath, epistaxis and two episodes of hemoptysis. Over
the previous 6 months, she had been seen multiple times
in our ED and Medicine Clinic for nasal congestion,
symptoms of upper respiratory infections and mild si-
nusitis, one episode of epistaxis, and she had also been
referred to ophthalmology for bilateral scleral injection
and serous discharge. She was subsequently diagnosed
with non-necrotizing anterior scleritis 4 days prior to ad-
mission. At that time she was referred to our Medicine
Clinic for a new onset of rash on her torso and legs, a
painful ulcer on her lip, migratory polyarthralgias and
digital swelling. Other past medical history was non-
contributory and she reported no toxic habits, or use of
any medication.
Because of significant hypoxia and respiratory distress,
the patient was admitted to the Medical ICU. A physical
examination revealed tachypnea and use of accessoryCentral Ltd. This is an Open Access article distributed under the terms of the
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prominent vessels of her nasal mucosa with a small ul-
ceration in her right nasal cavity, few blisters and ulcers
on her lower lip (consistent with herpes simplex) and
one right pharyngeal pillar ulcer. Examination of the
skin revealed palpable purpura on the lower abdomen
and both thighs. She had bilateral symmetric arthritis of
the metacarpophalangeal and proximal interphalangeal
joints. On examination of her lungs there were bilateral
fine crackles. The remainder of the examination was un-
remarkable. She was very hypoxic (PO2 50mmHg on
FiO2 100%), which did not improve with bilevel positive
airway pressure and she was endotracheally intubated
shortly after her admission to the Medical ICU.
Microcytic anemia had developed (hemoglobin 10.4g/dL
from 13.2g/dL 4 months ago), mild thrombocytosis
(600,000 per microliter) was present and her erythrocyte
sedimentation rate (ESR) was 100mm/hour. There was
mild elevation of transaminases; blood urea nitrogen and
creatinine were normal. A urine analysis revealed micro-
scopic hematuria and significant proteinuria (>300mg/dL),
without any casts.
An out-patient chest radiograph performed 4 days prior
to the patient’s admission revealed bilateral alveolar infil-
trates (Figure 1A). Her admission chest radiograph
revealed significant interval change, consistent with DAH
(Figure 1B). Her antinuclear antibody panel (ANA) and
rheumatoid factor (RF) titers were negative, but her
cytoplasmic (c)-ANCA autoantibodies were positive at
59U/mL. Her perinuclear (p)-ANCA and antiglomerular
basement membrane (GBM) immunoglobulin titers were
both negative. The result of the patient’s purified protein
derivative test was negative and three acid-fast bacilli
smear tests of sputum were negative. A bronchoalveolar
lavage (BAL) confirmed alveolar hemorrhage. Her BAL
cultures revealed methicillin-resistant Staphylococcus
aureus (MRSA). Two sets of blood cultures drawn on
admission were negative. A nasal endoscopic examinationFigure 1 Posterior-anterior chest X-ray 4 days prior to admission. (A)
showing significant interval change consistent with diffuse alveolar hemorrshowed left synechia and whitish debris on the lateral wall
and a small right ulcerated area on the right wall of her
nasal septum. The nasal biopsy report described non-
specific acute and chronic inflammation changes, ulcer-
ation and necrosis, but no granulomas were noted.
Discussion
DAH is a life-threatening clinical syndrome caused by a
variety of conditions, predominantly pauci-immune or
immune deposit-mediated capillaritis, infections and
drug reactions [1]. This patient’s progressive multisystem
complaints over a period of months, along with the ele-
vated ESR, anemia and thrombocytosis, strongly sup-
ported the diagnosis of systemic vasculitis. The
differential diagnosis included WG, microscopic polyan-
giitis, Churg–Strauss syndrome and anti-GBM or Good-
pasture syndrome (more common in men), as well as
systemic lupus erythematosus and, less likely, Behçet’s
disease and rheumatoid arthritis [2].
This patient’s clinical course, as well as the strongly
positive c-ANCA with negative RF, ANA, p-ANCA and
anti-GBM titers were considered diagnostic of WG [1,2].
Our patient had manifested many typical WG symptoms
and signs, including sinusitis (51% on presentation),
nasal congestion and epistaxis (36%), conjunctivitis with
subsequent episcleritis (5% and 6%, respectively), frank
arthritis (32%) and a purpuric rash (13%) [3].
DAH may represent an initial and rare manifestation
of the disease [2,4]. Approximately 40 cases have been
reported so far [2]. Usually, renal involvement is severe
and the leading cause of mortality [1-3], but our patient’s
renal function was preserved. However, her significant
proteinuria and microscopic hematuria were also sug-
gestive of WG-associated glomerulonephritis, despite
the absence of red blood cell casts, similar to a previous
report [4]. The biopsy results of her nasal cavity were
non-diagnostic, most probably as a result of chronic
inflammation.Showing bilateral infiltrates. (B) Repeat chest X-ray on admission
hage.
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cation of infectious agents [1] but a primary bacterial,
viral or fungal pneumonia alone could not have fully
explained the patient’s presentation. It should be noted
though that herpes simplex virus infection or reactiva-
tion as well as Staphyloccocus aureus carriage, both of
which our patient had at the time of presentation, have
been associated with WG flares [3,5].
The combination of high-dose corticosteroids and
cyclophosphamide is the mainstay of treatment for the
vasculitis, and disease resistance to this combination is
rare. Intravenous cyclophosphamide (0.5g/m2 to 1.0g/m2
body surface area) is started at the same time as pulse
methylprednisolone (1g intravenous for 3 days), followed
by high-dose steroid treatment adjusted to response.
Cyclophosphamide is repeated at intervals of 4 weeks.
On the second day, we decided to proceed with plasma
exchange (PE) because it has been used in some centers
for fulminant disease causing pulmonary–renal failure
requiring organ support, or within the first days follow-
ing alveolar hemorrhage [6]. In our case, PE was indi-
cated and used for five daily sessions because our patient
with DAH had showed no improvement, with very high
oxygen requirements on the ventilator.
Data have suggested that treatment with trimethoprim-
sulfamethoxazole (TMP-SMX) may be beneficial in redu-
cing the incidence of relapses in patients with WG in
remission [7], because this antibiotic could act by elim-
inating the offending microbe and thereby stop the initi-
ating stimulus [8]. TMP-SMX can be used in the initial
phase of WG and some patients with less severe general-
ized WG [9]. TMP-SMX was prescribed on discharge for
Pneumocystis carinii prophylaxis [10]. After a prolonged
hospitalization, complicated by febrile neutropenia, MRSA
bacteremia and Pseudomonas pneumonia, treated success-
fully with broad spectrum antibiotics, our patient was
extubated and discharged to the Rehabilitation Unit.Conclusions
WG presenting as DAH is uncommon. However, the
recognition of multisystem disease involving joints, kid-
ney, eye and lung is critical for diagnosing Wegener's
vasculitis. WG can progress or initially manifest as
DAH, in which case immediate and aggressive treatment
with pulse steroids, high-dose cyclophosphamide and PE
can be life-saving.Consent
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